Heron Therapeutics (HRTX) EPS (Basic) Growth (5y) (2016 - 2026)
Powered by 
Analysis
Heron Therapeutics (HRTX) EPS (Basic) Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.38 Bn | 192.39 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.22 Bn | 177.04 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.28 Bn | 123.42 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.96 Bn | 73.97 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.49 Bn | 55.30 Bn | 1.37 Bn |
| 6 | Moderna | 53.90 Bn | 48.76 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.41 Bn | 30.11 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.08 Bn | 29.08 Bn | 1.16 Mn |
| 10 | Heron Therapeutics | 61.65 Mn | 18.99 Mn | 26.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.49% |
| Mar 31, 2026 | 46.45% |
| Dec 31, 2025 | 15.08% |
| Sep 30, 2025 | 48.25% |
| Jun 30, 2025 | 55.53% |
| Mar 31, 2025 | 15.27% |
| Dec 31, 2024 | 15.76% |
| Sep 30, 2024 | 41.92% |
| Jun 30, 2024 | 42.08% |
| Mar 31, 2024 | 47.82% |
| Dec 31, 2023 | 39.60% |
| Sep 30, 2023 | 20.38% |
| Jun 30, 2023 | 8.07% |
| Mar 31, 2023 | 19.19% |
| Dec 31, 2022 | 31.37% |
| Sep 30, 2022 | 13.22% |
| Jun 30, 2022 | 9.16% |
| Mar 31, 2022 | 9.16% |
| Dec 31, 2021 | 15.25% |
| Sep 30, 2021 | 16.66% |